Quarterly report [Sections 13 or 15(d)]

Revenues from Contracts and Significant Customers (Tables)

v3.25.2
Revenues from Contracts and Significant Customers (Tables)
6 Months Ended
Jun. 30, 2025
Revenues from Contracts and Significant Customers  
Schedule of disaggregation of total revenues

Three months ended June 30, 

Six Months Ended June 30, 

($ in thousands)

    

2025

    

2024

    

2025

    

2024

Emrosi

$

2,795

$

$

4,865

$

Qbrexza

6,949

6,836

12,110

11,853

Accutane

3,395

5,719

7,050

11,538

Amzeeq

879

1,205

1,979

1,960

Zilxi

256

369

682

642

Other / legacy product revenue

735

726

1,462

1,892

Revenue – related party

 

 

41

 

 

41

Other revenue

1,404

1,404

 

Total net revenue

$

16,413

$

14,896

$

29,552

$

27,926